Uganda-based drug manufacturer, Cipla Quality Chemical Industries Limited has landed a juicy deal after being granted permission to export medicine to over thirty countries of which they were initially in deals with eleven countries out of the thirty.
Mr. Nervin Bradford, the Cipla Quality Chemical Industries Limited chief executive officer yesterday informed the lucrative opportunity involves the export of drugs such as antiretrovirals and malaria medicines which include efavirenz 600mg, lamivudine 300mg, tenofovir 300mg, and Artemether 20mg.
He additionally said, the drug maker will also export to the two regions lumefantrine 120mg, and tenofovir 300mg or lamivudine 300mg.
“For the first time, a manufacturer from East Africa has received approval to supply drugs to Ecowas. The approval not only bestows a vote of confidence in Cipla but also in Uganda’s pharmaceutical industry,” informed Mr. Nevin.
Cipla will make it’s maiden appearance on markets in countries like Benin, Burkina Faso, Cape Verde, Cote d’Ivoire, Gambia, Guinea, Guinea Bissau, Mali, Niger, Nigeria, Ghana, Senegal, Sierra Leone, Togo and Liberia.
Other countries to which Cipla Quality Chemical Industries Limited manufactured drugs will be exported also include Namibia, Malawi, Zimbabwe, Mozambique, Botswana, the DR Congo, Tanzania and South Africa under Zazibona.
Fred Kamunyu – I did not partake in the Covid-19 cash
The 2021/2022 financial year budget exclusive of the National Development Plan III strategies
Uganda poultry imports likely to receive another ban from Kenya
URA Receives Trade Facilitation Boost for Marine and Border Surveillance Operations
The Chief Executive Officer also assured that the company has upgraded it’s manufacturing facility to match up to the new capacity of the recently included countries to it’s suppliers’ list.